New Research Uncovers T Cell Role in Alzheimer’s Beyond the Brain

New research from Washington University School of Medicine in St. Louis highlights an unexpected role of T cells in Alzheimer's disease. Traditionally viewed as immune defenders, these T cells appear to travel from lymph nodes to the brain, where they may aggravate neurodegeneration. The study, published on September 3 in Nature Neuroscience, offers fresh insights into immune responses linked to Alzheimer's and tauopathies.

David M. Holtzman, MD, a leading figure in neuroscience at WashU, emphasizes that this discovery signifies some disease processes begin outside the brain, which could simplify targeting treatment strategies. "One of the challenges with neurological diseases is ensuring that therapies cross the blood-brain barrier, but we may not need to deliver drugs directly to the brain to mitigate damage," Holtzman explained. "Existing therapies manipulating T cells, effective in other conditions, deserve exploration for neurodegenerative diseases."

This research builds on previous work in Holtzman’s lab, which successfully demonstrated that depleting T cells in the brain curtailed neurodegeneration in mice modeling tau-related damage. However, the source of these T cells and their migratory cues remained unclear.

Tracking T Cells back to Their Origins

Holtzman's research team investigated the role of classical dendritic cells type 1 (cDC1) in these processes. Typically, T cells depend on these dendritic cells to identify targets for attack, and intriguingly, cDC1 are scarce within the brain. This lack suggested to researchers that the activation of T cells likely originates outside the central nervous system.

Performing experiments with mouse models, they effectively eliminated dendritic cells from lymph nodes, which led to a striking outcome: the migration of elevated T cell populations, particularly CD8 T cells, into the brain was substantially reduced. Importantly, this did not alter the presence of tau tangles in the brain, nor did it impact the overall cognitive functions of the mice. Thus, the evidence hints at the potential of targeting T cell activity to slow cognitive decline in Alzheimer's patients, even in the presence of tau protein accumulations.

Understanding the Signals

Despite these compelling findings, researchers are still deciphering the exact signals prompting dendritic cells to activate T cells. One theory suggests that damage induced by tau proteins may release cellular material that travels to lymph nodes, where dendritic cells recognize it as a target, leading T cells to accumulate in the brain.

With the dynamics of this immune pathway uncovered, Holtzman’s group is now exploring whether interference with dendritic cell function during midlife—around the time tau tangles typically begin to form—can yield the same protective effects observed when these cells were blocked before birth. This line of inquiry could open new avenues for treatment, allowing researchers to target immune processes at stages prior to significant neurodegeneration.

Future Implications for Treatment

Identifying the specific signals that redirect T cells into the brain could lead to novel strategies to prevent neuroinflammation and the consequent brain damage seen in Alzheimer's disease. "Just a few years ago, many, including myself, doubted that the immune response played a role in neurodegenerative diseases characterized by protein accumulations," Holtzman noted. The involvement of dendritic cells in these processes is an exciting development that broadens potential therapeutic approaches to tackle this devastating disease.

These findings not only expand the understanding of Alzheimer’s pathology but also emphasize the need to rethink treatment paradigms. By focusing on the immune response and its modification outside the brain, researchers might develop methods that offer more approachable interventions for neurodegenerative diseases.

Materials provided by WashU Medicine. Note: Content may be edited for style and length.

Don’t Miss: Saturn, Halley’s Comet Meteors and the Seven Sisters Light Up October

Scientists Discover 5 Hidden Forms of a Liver Disease Affecting 30% of Adults

Could Vitamin C Help Stop Leukemia Before It Starts?

Study Finds Natural Dairy Trans Fats Behave Very Differently From Industrial Fats

Stay informed with ScienceDaily's free email newsletter, updated daily and weekly. Or view our many newsfeeds in your RSS reader:

Keep up to date with the latest news from ScienceDaily via social networks:

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?